Skip to content
Aperlena

Germany - Medicines - Open-House Contracts 2026-2

Original Deutschland - Arzneimittel - Open-House-Verträge 2026-2

Open Contract notice 588 days left
Watch this tender

Deadline 1 May. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 17 Apr, questions by 17 Apr, draft by 24 Apr. Log in

  1. Published
  2. Today
  3. Deadline open for 741 days
  4. Awarded pending

Summary

Machine-generated summary

This German tender concerns open-house discount contracts under Section 130a(8) of SGB V for various pharmaceutical active ingredients. Any suitable and interested pharmaceutical company or consortium may sign or join the contracts at any time during the contract period, under uniform contract terms and a uniform access procedure. Medicines on the BfArM list of paediatric medicines under Section 35(5a) SGB V are excluded. The earliest contract start is 1 July 2026 and the contract ends on 30 June 2028. Interested companies should submit the signed discount contract in duplicate, preferably by email in advance. No estimated value or submission deadline is stated.

Description

Open-House-Verträge für diverse Wirkstoffe ab frühestens 01.07.2026 bis 30.06.2028. Im Open House Verfahren sind Arzneimittel entsprechend der BfArM-Liste nach § 35 Abs. 5a SGB V (Kinderarzneimittel) ausgeschlossen. Gegenstand dieser Veröffentlichung ist der Abschluss von Verträgen nach § 130a Abs. 8 SGB V über verschiedene Wirkstoffe im Rahmen eines sogenannten Open-House-Verfahrens. Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss bzw. Beitritt zu einem Rabattvertrag nach § 130a Abs. 8 SGB V über den genannten Wirkstoff angeboten. Der früheste Vertragsbeginn ist der 01.07.2026, Vertragsende ist der 30.06.2028. Ein Beitritt zu diesem Open-House-Verfahren ist innerhalb der Vertragslaufzeit jederzeit möglich. Bitte seien Sie so nett und übersenden uns bei Interesse, gerne vorab per E-Mail, den in 2-facher Ausfertigung unterschriebenen Rabattvertrag unter Berücksichtigung der Kinderarzneimittel-Liste des BfArM.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

More from this buyer

Full buyer profile

4 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 41 €17.4M Aug 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
B. Braun Deutschland GmbH & Co. KG 10 €1.3M Jun 2026

Based on 1001 awards with a linked company profile over the last 2 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now May 1, 2028, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€9,331,010
11,573 open across Europe right now
Buyer track record on Aperlena
6 notices tracked · 0 awarded

Never miss a tender like this

98 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close